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Aim.T oeval uat ediﬀusionweightedimage-MRI(DWI)asasinglediagnosticnoninvasiveMRItechniqueforprostatecancer(PCa)
diagnosis. Material and Methods. A prospective study was conducted between July 2008 and July 2009. Candidates patients were
equal or more than 40 years old, with suspicious digital rectal examination (more than clinical T2) or PSA >4ng/mL. Informed
consent was signed. DWI-MRI was performed at 1.5T with a body coil combined with a spine coil in consecutive 100 cases. The
histopathology of biopsies has been used as reference standard. Two examiners were evaluating MRI and TRUS, both of them
were blinded regarding pathological ﬁndings. Accuracy, speciﬁcity, and sensitivity were statistically analyzed. Results.B a s e do n
pathological diagnosis: group A (cancerous); 75 cases and group B (non-cancerous); 25 cases. Mean age was 65.3 and 62.8 years in
groupsAandB,respectively.MeanPSAwas30.7and9.2ng/mLingroupsAandB,respectively.SensitivityofDWIwas58.3%while
speciﬁcity was 83.8%. Accuracy of lesion detection was 52.4–77.8% (P<0.05). Moreover, DWI at ADC value 1.2 × 10−3 mL/sec
could determine 82.4% of true positive cases (P<0.05). ADC values were lower with Gleason score ≥7( P<0.05). Conclusion.
DWI could represent a non invasive single diagnostic tool not only in detection and localization but also in prediction of Gleason
score whenever DWI is used prior to invasive TRUS biopsy. Furthermore, targeted single biopsy could be planned after DWI to
minimize patient morbidity by invasive techniques.
1.Introduction
As it is known, prostate cancer is a major health problem,
and exploration of noninvasive imaging methods that have a
high speciﬁcity and sensitivity is still critically needed.
Magneticresonanceimaging(MRI)hasbeenwidelyused
for pretreatment workup in patients with prostate cancer
(PCa). Newly applied MRI techniques as diﬀusion weighted
image(DWI)areconsideredasapromisingtechnology.DWI
provides functional information about the behavior of water
molecule in the tissue. DWI oﬀers more power to evaluate
PCa through various points: detection [1], localization [2],
and tumor aggressiveness [3].
In order to assess this value simultaneously in one group
of patients, a prospective study was conducted. Our aim is
to study the value of DWI as single technique in high-risk
patients (elevated PSA and more than clinically T2) as fully
informative diagnostic tool.
2.MaterialandMethods
2.1. Patients. A prospective ethically approved study was
conducted on 100 patients. Inclusion criteria were patients
more than or equal to 40 years, aged abnormal digital
rectal examination (more than clinical T2), PSA ≥4ng/mL
with signed consent. Patients with prior PSA measurements
and biopsy, prostatic operations, or positive family histories
of PCa with previous transrectal ultrasound (TRUS) were
excluded. This study was carried out between July 2008
and July 2009. Diagnosis was conﬁrmed by histopathology2 The Scientiﬁc World Journal
through TRUS biopsy. The interval time between MRI
(earlier) and TRUS biopsy (later) ranged between14 and 21
days (mean: 16.7 days).
2.2. MR Technique. Patients underwent MRI at 1.5-T MRI
(SIGNAHorizon,GeneralElectricMedicalSystems,Milwau-
kee, WIS) using surface coil. Initially, high spatial resolution
T2W images of the prostate were obtained using TR =
7.000–8.000ms, TE = 90–102ms, band width = 20–83kHz,
256 × 256 matrix, slice thickness of 3mm, intersection
gap of 1mm, and ﬁeld of view (FOV) = 20cm. DWI were
then obtained, under free breathing, using monodirectional
gradients and a multisection fast spin-echo-type (FSE)
echoplanar sequence in the axial plane by using a body coil
with the following parameters: TR = 8.000ms, TE = 61.2ms,
band width = 142kHz, 256 × 256 matrix, slice thickness of
5mm, intersection gap of 0mm, and FOV = 36cm, seven
excitations, water excitation with b value of 0 and 800/mm2.
Thirty to 54 slices were obtained in 60–120sec. to cover the
pelvis in each patient.
2.3. Image Analysis. Image was analyzed using the function
tool software (General Electric Medical System, Milwau-
kee, Wisconsin). Blinded to the results of clinical and
histopathology data, two radiologists interpreted the MRI
images. Discrepancies and equivocal cases were resolved by
consensus either positive or negative. PCa appeared on DWI
with a b value of 800/mm2 as high signal intensity relative
to bladder wall and the surrounding urine. Any lesion on
peripheralzonehaslowapparentdiﬀusioncoeﬃcient(ADC)
value than 1 × 10−3 mm2/sec. is considered negative. In our
study, for statistical purposes, focal lesion was identiﬁed by
tumor involved one lobe with <3 cores and multifocal lesion
wasbilateraldistributionofthepositivecoresorinvolvement
of more than 3 cores.
2.4. Diagnostic Criteria. When DWI was used, any prostatic
lesion showing a decrease on ADC map with ﬂuid restriction
(high SI at b = 800 and low SI at b = 0) was considered
malignant (Figure 3). The regions of interest circles were
placed in the suspected areas as large as possible for
cancerous zones and at random more than twice in each
benign zone, and the mean value was calculated as the value
of ADC for each noncancerous zone. ADC value of each
zone was recorded, and the series was arranged in order. The
prostate was divided, corresponding to biopsy sites into 6
regions on MRI image to facilitate the localization accuracy
comparison.
2.5. Prostate Biopsy. All patients underwent TRUS guided
biopsy (12-cores: apical, midzonal and, basal; 2 biopsies
per each zone). Whenever PSA was high and biopsies
were negative, rebiopsy was done after 2 weeks. The TRUS
machine:BandKmedicalpanther(7.5MHzBruelandKjaer,
model 2002 (Naerum, Denmark)). A local anesthetic (2%
lidocaine jelly (10mL)) has been instilled intrarectally ten
minutes before TRUS. Biopsy was taken with 18G needles
driven by a spring-loaded gun. An individual histological
analysis for each sample site was performed. The PCa
locations were assigned deﬁnitely corresponding zones.
2.6. Statistical Analysis. All data were analyzed using SPSS
16.0 for Windows (SPSS Inc., Chicago, IL, USA). ADC value
was evaluated by means of receiver operator characteris-
tics (ROC) analysis. The area under the ROC curve was
calculated for comparison. Sensitivity, speciﬁcity, positive
predictive value (PPV), and negative predictive value (NPV)
for DWI had been calculated in order to evaluate the
reliability. Chi-square test was used when appropriate, with
consideration of statistical signiﬁcance at P<0.05.
3. Results
On histopathological examination of 1692 prostatic biopsies
(100 cases): 75 cases were harboring one or more cancerous
focus in their biopsies (group A) and 25 cases proved to be
noncancerous (group B). Within group B, 15 cases had BPH
and 10 cases had chronic prostatitis. Forty-one cases had
been subjected to second set biopsies.
Only 92 cases completed the DWI-MRI study (68 cases
in group A, and 24 cases in group B). Mean age of the
studied group was 65.03 years (SD ± 7.13 years). Mean
PSA was 26.3ng/mL (SD ± 24.2ng/mL). Mean volume of
the gland was 60.09 grams (SD ± 28.7 grams). According
to radiological TNM staging, 13/68 cases were T3 prostate
cancer. While 16/68 cases were stage T4.
DWI-MRI was able to identify 67/92 cases (72.8%) as
positivecases.However,25/92cases(27.2%)wasidentiﬁedas
negative of malignancy. Diagnosis of DWI was in agreement
withmalignanthistopathologicalﬁndingin57caseswhile14
cases were negative in correlation with their corresponding
nonmalignant histopathology. The speciﬁcity was 83.3%,
sensitivity was 58.3%, PPV was 85.1%, NPV was 56%, and
accuracy was 77.2%.
Localization of the tumor focal lesion was in agreement
with histopathology map in 11/21 cases (52.4%); however,
the remaining 10/21 cases were seen as multifocal lesions.
While28/36cases(77.8%)wereidentiﬁedasmultifocalwhen
they were compared with the histopathological map, P<
0.020.
Receiver operating characteristics (ROC) curve of ADC
values of diﬀerent prostatic zones was performed to deﬁne
the most reliable cutoﬀ point to diﬀerentiate cancerous and
noncancerous conditions. ADC value of right peripheral
zone: area under the curve: 0.781, P = 0.0001, 95% conﬁ-
denceinterval:0.666–0.895,ADCofleftperipheralzone:area
under the curve: 0.682, P = 0.011, 95% conﬁdence interval:
0.547–0.816 Figure 1.A D Cv a l u eo fc e n t r a lz o n e :a r e au n d e r
the curve: 0.749, P = 0.001, 95% conﬁdence interval: 0.623–
0.874, Figure 2.
To diﬀerentiate cancerous and noncancerous status: at
commony used ADC cutoﬀ value 1 × 10−3 mm2/seconds,
the sensitivity was ranged between 81.8 and 86.4% and
86.4% on peripheral (right and left zones) and central zone,
respectively. The speciﬁcity was 41.5–43.1% on peripheral
zone and 29.2% on central zone. However, at ADC cutoﬀ
value 1.2 × 10−3 mm2/sec.; sensitivity ranged between 72.2The Scientiﬁc World Journal 3
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Figure 1: Receiver operating characteristics (ROC) curve of ADC
values of peripheral prostatic zones (ADC of right peripheral zone:
area under the curve: 0.781, P = 0.0001, 95% conﬁdence interval:
0.666–0.895; ADC of left peripheral zone: area under the curve:
0.682, P = 0.011, 95% conﬁdence interval: 0.547–0.816).
and 86.4%, with speciﬁcity range between 50.8–63.2%.
While the central zone reached 86.4% sensitivity and 38.5%
speciﬁcity at the same cutoﬀ point. Furthermore at ADC
value 1.5 × 10−3 mm2/sec., the sensitivity was 68.2–77.3%
and speciﬁcity range was 73.8–75.4% on peripheral zones.
Ontheprostaticcentralzoneatthesamevalue,thesensitivity
was 68.2% and speciﬁcity was 70.2% (P<0.05).
Of clinical importance, the ADC value was correlated
with the pathological Gleason score. Table 1 shows a statis-
tical signiﬁcant diﬀerence between Gleason score less than 7
a n dA D Cv a l u ea r o u n d1 . 4× 10−3 mm2/sec. in all measured
zones, P<0.05. In other words, ADC value less than 1.4 ×
10−3mm2/sec. was associated with Gleason score more than
or equal to 7, P<0.05.
4. Discussion
MRI is the imaging tool of choice in the evaluation of
prostate cancer. DWI-MRI has many advantages over other
MRI techniques, it is non invasive (unlike contrast enhanced
or endorectal MRI), acquisition time is less than 2 minutes
(unlike spectroscopy), and has good speciﬁcity (unlike T2-
Weighted MRI). However, the limitations are its poor spatial
resolution and the potential risk of image distortion because
of hemorrhages after prostatic biopsy [4].
In high-risk patients (elevated PSA and clinically more
than T2) who have a limited surgical chance. Especially with
late tumorstages,precise delineation of tumor is essential for
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Figure 2: Receiver operating characteristics (ROC) curve of ADC
values of central prostatic zones (ADC of central zone: area under
the curve: 0.749, P = 0.001, 95% conﬁdence interval: 0.623–0.874).
Table 1: Correlation between ADC values and Gleason score.
ADC right
peripheral
zone mean
(± SD)
ADC left
peripheral
zone mean
(± SD)
ADCcentral
zone mean
(± SD)
Gleason score ≤6
(n = 28)
1.49
(±0.437)
1.4656
(±0.509)
1.415
(±0.382)
Gleason score ≥7
(n = 39)
1.045
(±0.366)
1.003
(±0.387)
1.219
(±0.426)
P value 0.0001 0.0001 0.060
radiotherapyplanning[2].Thiswillbeenhancedinhigh-risk
patients as MRI detection of PCa is dependent on tumor size
[5, 6].
Furthermore in order to facilitate targeted biopsy which
has a higher detection rate than conventional biopsies [7],
avoiding unnecessary biopsies without missing PCa in men
with elevated PSA rather than avoiding annoying biopsies-
related complications are aspects that require focus.
In our study, DWI has the ability to identify tumor in
comparison to malignant histopathology. Detection ability
has speciﬁcity 83.8%, sensitivity 58.3%, PPV 85.1%, NPV
56%, and accuracy 77.2%. Our results were in agreement
with Shimizu et al. [8] (DWI has sensitivity 56.7% and PPV
was 86.4%). While Chen et al. [9]r e p o r t e dh i g hs e n s i t i v i t y
and speciﬁcity (82.4%, 81.6%, resp.).
In our study we found accuracy of tumor detection
on DWI-MRI was high (82.4%, P<0.05) with ADC
values around 1.2 × 10−3 mm2/sec. Chen et al., in their
study, found that ADC value less than 1.3 × 10−3 mm2/sec.
increased speciﬁcity and sensitivity of tumor detection
to 81.6 and 82.4% [9]. No studies in English literature4 The Scientiﬁc World Journal
(a) (b)
Figure 3: Example of 62-years-old male patient with cancer prostate and PSA >10ng/mL. At the corresponding DWI/ADC map (a) there is
a relative hyperintense lesion at the medial aspect of the right PZ at b = 800 and it is hypointense at b = 0 and at ADC map (b).
discuss localization power of DWI as sole noninvasive MRI.
Localization sensitivity and speciﬁcity were 84%, 82%, DWI
endorectal coil in study of Ya˘ gci et al. [10]. In our result,
localization of the cancerous focal lesion was in agreement
of histopathology map in 52.4% while multifocal were iden-
tiﬁed in 77.8% accurately in our study. However, based on
our result, we assume that DWI has more precise localization
whenever more than 3 foci are presented. According to our
results we suppose that whenever DWI is used prior to
invasive biopsy, and through its role towards targeted biopsy
(localization accuracy), it could save time and cost and lower
the complications that may be yielded by biopsy.
Woodﬁeld et al. suggested an inverse relationship
between ADC value of DWI and Gleason score [11]. We
agreed with them and also we concluded ADC value 1.4 ×
10−3 mm2/seconds as cutoﬀ point that can discriminate
between low-risk (Gleason ≤ 6) and high-risk (Gleason ≥
7) prostate cancer.
Among our cases, 56% of them had high Gleason score
and all cores are positive in 62.7% of cases. Shimizu et al.
documented that sensitivity of tumor detection by MRI is
increasing with tumor size and Gleason score [8]. However,
they found that PPV of DWI and T2W was 86.4% and 83%.
While in our study PPV were 85.1% and 81.1% for DWI and
T2W, respectively.
In brief, DWI as single noninvasive tool is an informative
MRImodality.Itwasabletoanswerquestionsoflocalization,
tumor detection, and predication of pathological Gleason
scores. Targeted single biopsy could be planned after DWI
to minimize patient morbidity by invasive techniques.
A limitation of our study is that we compared DWI with
histopathology biopsy results and not with prostatectomy
specimens. This was due to the limited cases have been
operated on. In view of high-risk sector of our studied
patients (elevated PSA, more than clinical T2) with high
radiological staging (T3 or more: 42.6%), all these factors
hinder the possibility of radical prostatetcomy.
5. Conclusion
DWI could represent a non invasive single diagnostic tool
not only in detection and localization but also in predic-
tion of Gleason score. DWI has acceptable identiﬁcation
power (accuracy was 77.2% and was speciﬁcity 83.8%).
DWI could localize multifocal lesion (77.8%) better than
focal lesion (52.4%). Detection rate was better with ADC
value 1.2 × 10−3 mm2/seconds, as cutoﬀ value, than 1 ×
10−3 mm2/seconds (speciﬁcity: 50.8–63.2%). Lastly, on ADC
value: 1.4 × 10−3 mm2/seconds, DWI can diﬀerentiate
Gleason score more or less than 7.
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